Onconase Shows Unique Promise In Treating Mesothelioma
RTT News June 27, 2006
Alfacell Corp. said that according to the research findings published in National Academy of Sciences Journal, the company's anti-cancer drug Onconase might be one of the most effective methods of treatment for mesothelioma and lung cancer caused by asbestos.
FDA approves Alimta-Cisplatin Combination for treatment of Asbestos-Related Cancer
Press Release February 2, 2004
The first and only drug regimen proven to help patients with an asbestos-related cancer live longer was approved today by the U.S. Food and Drug Administration.
Experimental Cancer Drug Tarceva
Reuters October 9, 2002
OSI Pharmaceuticals Inc. is more confident than ever of the potential of its experimental cancer drug Tarceva (erlotinib HCl), even after the failure of a similar drug in a major clinical study this summer, OSI Chairman and CEO Dr. Colin Goddard told investors at the UBS Warburg Global Life Sciences conference here on Wednesday.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment